Role of Magnetic Resonance Spectroscopy in Evaluation of Congenital/Developmental Brain Abnormalities

Seminars in Ultrasound, CT and MRI

Volumn 32, Issue 6, 2011, Pages 510-538

  Shekdar, Karuna ^a   Wang, Dah Jyuu ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CELL MARKER; CHOLINE; CREATININE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; UREA;

ADRENOLEUKODYSTROPHY; ARTICLE; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN LEVEL; BRAIN TUMOR; CANAVAN DISEASE; CORTICAL DYSPLASIA; DEVELOPMENTAL DISORDER; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GLOBOID CELL LEUKODYSTROPHY; HAMARTOMA; HETEROTOPIA; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IN VIVO STUDY; LACTIC ACIDOSIS; MAPLE SYRUP URINE DISEASE; METACHROMATIC LEUKODYSTROPHY; MUCOPOLYSACCHARIDOSIS; NEUROIMAGING; NIEMANN PICK DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHENYLKETONURIA; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; UREA CYCLE DISORDER; WHITE MATTER;

BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 81855175413     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2011.08.001     Document Type: Article

References (40)

1. Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases 1998, Marcel Dekker, Inc, New York. R. Else, B.R. Danielson (Eds.).
2. Panigrahy A., Nelson M.D., Blüml S. Magnetic resonance spectroscopy in pediatric neuroradiology: Clinical and research applications. Pediatr Radiol 2010, 40:3-30.
3. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987, 508:333-348.
4. Bottomley P.A., Edelstein W.A., Hart H.R., et al. Spatial localization in 31P and 13C NMR spectroscopy in vivo using surface coils. Magn Reson Med 1984, 1:410-413.
5. Frahm J. Localized proton spectroscopy using simulated echoes. J Magn Reson Imaging 1987, 75:502-508.
6. Ordidge R.J., Connelly A.B. Image-selected-in-vivo spectroscopy(ISIS): A new technique for spatially selective NMR spectroscopy. J Magn Reson Imaging 1986, 66:283-294.
7. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993, 30:672-679.
8. Hunter J.V., Wang Z.J. MR spectroscopy in pediatric neuroradiology. Magn Reson Imaging Clin N Am 2001, 9:165-189. ix.
9. Tallan H.H. Studies on the distribution of N-acetyl-L-aspartic acid in brain. J Biol Chem 1957, 224:41-45.
10. Baslow M.H. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: Role in glial cell-specific signaling. J Neurochem 2000, 75:453-459.
11. Pfefferbaum A., Adalsteinsson E., Spielman D., et al. In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging. Magn Reson Med 1999, 41:276-284.
12. Kreis R., Ernst T., Ross B.D. Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993, 30:424-437.
13. Lien Y.H., Shapiro J.I., Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990, 85:1427-1435.
14. Videen J.S., Michaelis T., Pinto P., et al. Human cerebral osmolytes during chronic hyponatremia: A proton magnetic resonance spectroscopy study. J Clin Invest 1995, 95:788-793.
15. Kreis R., Ross B.D., Farrow N.A., et al. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992, 182:19-27.
16. Daikhin Y., Yudkoff M. Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 2000, 130(suppl):1026S-1031S.
17. Erecińska M., Silver I.A. Metabolism and role of glutamate in mammalian brain. Prog Neurobiol 1990, 35:245-296.
18. Condon B., Oluoch-Olunya D., Hadley D., et al. Early 1H magnetic resonance spectroscopy of acute head injury: Four cases. J Neurotrauma 1998, 15:563-571.
19. Haseler L.J., Arcinue E., Danielsen E.R., et al. Evidence from proton magnetic resonance spectroscopy for a metabolic cascade of neuronal damage in shaken baby syndrome. Pediatrics 1997, 99:4-14.
20. Holshouser B.A., Ashwal S., Shu S., et al. Spectroscopy in children with acute brain injury: Comparison of short and long echo time acquisitions. J Magn Reson Imaging 2000, 11:9-19.
21. Ross B.D., Ernst T., Kreis R., et al. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging 1998, 8:829-840.
22. Wang Z., Sutton L.N., Cnaan A., et al. Proton MR spectroscopy of pediatric cerebellar tumors. AJNR Am J Neuroradiol 1995, 16:1821-1833.
23. Bluml S., Seymour K.J., Ross B.D. Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled, 31P MRS in in vivo human brain. Magn Reson Med 1999, 42:643-654.
24. Kreis R., Hofmann L., Kuhlmann B., et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002, 48:949-958.
25. Savic I., Lekvall A., Greitz D., et al. MR spectroscopy shows reduced frontal lobe concentrations of N-acetyl aspartate in patients with juvenile myoclonic epilepsy. Epilepsia 2000, 41:290-296.
26. Barkovich A.J., Kjos B.O. Gray matter heterotopias: MR characteristics and correlation with developmental and neurologic manifestations. Radiology 1992, 182:493-499.
27. Castillo M., Kwock L., Scatliff J., et al. Proton MR spectroscopic characteristics of a presumed giant subcortical heterotopia. AJNR Am J Neuroradiol 1993, 14:426-429.
28. Castillo M., Kwock L., Mukherji S.K. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996, 17:1-15.
29. Zimmerman R.A., Wang Z.J. The value of proton MR spectroscopy in pediatric metabolic brain disease. AJNR Am J Neuroradiol 1997, 18:1872-1879.
30. MRI of the Neonatal Brain 2002, W.B. Saunders, New York. M.A. Rutherford (Ed.).
31. Connelly A., Cross J.H., Gadian D.G., et al. Magnetic-resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency. Pediatr Res 1993, 33:77-81.
32. Barkovich A.J., Baranski K., Vigneron D., et al. Proton MR spectroscopy for the evaluation of brain injury in asphyxiated, term neonates. AJNR Am J Neuroradiol 1999, 20:1399-1405.
33. Cheong J.L., Cady E.B., Penrice J., et al. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: Metabolite peak-area ratios, relaxation times, and absolute concentrations. AJNR Am J Neuroradiol 2006, 27:1546-1554.
34. Hanrahan J.D., Sargentoni J., Azzopardi D., et al. Cerebral metabolism within 18 hours of birth asphyxia: A proton magnetic resonance spectroscopy study. Pediatr Res 1996, 39:584-590.
35. Hüppi P.S., Posse S., Lazeyras F., et al. Magnetic resonance in preterm and term newborns: 1H-spectroscopy in developing human brain. Pediatr Res 1991, 30:574-578.
36. Vigneron D.B., Barkovich A.J., Noworolski S.M., et al. Three-dimensional proton MR spectroscopic imaging of premature and term neonates. AJNR Am J Neuroradiol 2001, 22:1424-1433.
37. Girard N., Fogliarini C., Viola A., et al. MRS of normal and impaired fetal brain development. Eur J Radiol 2006, 57:217-225.
38. Heerschap A., Kok R.D., van den Berg P.P. Antenatal proton MR spectroscopy of the human brain in vivo. Childs Nerv Syst 2003, 19:418-421.
39. Keltner J.R., Wald L.L., Frederick B.D., et al. In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn Reson Med 1997, 37:366-371.
40. Mescher M., Merkle H., Kirsch J., et al. Simultaneous in vivo spectral editing and water suppression. NMR Biomed 1998, 11:266-272.